CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −126 | $483.42 | $61K | 0 |
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −14,625 | 170,250 | ||
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −7,875 | $146.03 | $1.1M | 21,940 |
| 2025-12-01 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion 10b5-1 | +21,000 | $146.03 | $3.1M | 29,142 |
| 2025-12-01 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,853 | $477.98 | $1.4M | 26,289 |
| 2025-12-01 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −4,198 | $479.11 | $2.0M | 22,091 |
| 2025-12-01 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −7,552 | $479.92 | $3.6M | 14,539 |
| 2025-12-01 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −3,858 | $480.95 | $1.9M | 10,681 |
| 2025-12-01 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,476 | $481.80 | $711K | 9,205 |
| 2025-12-01 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −903 | $483.04 | $436K | 8,302 |
| 2025-12-01 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −160 | $484.68 | $78K | 8,142 |
| 2025-12-01 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion · Stock Option 10b5-1 | −517 | 0 | ||
| 2025-12-01 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion · Stock Option 10b5-1 | −20,483 | 24,517 | ||
| 2025-12-01 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-12-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,590 | $480.28 | $764K | 2,540 |
| 2025-12-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,390 | $482.28 | $670K | 1,150 |
| 2025-12-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −520 | $483.38 | $251K | 630 |
| 2025-12-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $484.68 | $242K | 130 |
| 2025-12-01 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 54,000 | ||
| 2025-11-28 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
Page 176 of 214 · 4,273 trades